Akums Drugs and Pharmaceuticals IPO vs Interarch Building Products IPO

Comparision between Akums Drugs and Pharmaceuticals IPO and Interarch Building Products IPO.

IPO Details

Akums Drugs and Pharmaceuticals IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Interarch Building Products IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

	Akums Drugs and Pharmaceuticals IPO	Interarch Building Products IPO
Logo
Issue Category	Mainline	Mainline
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	BSE, NSE	BSE, NSE
Lead Managers	ICICI Securities Limited Axis Bank Limited Citigroup Global Markets India Private Limited Ambit Private Limited	Ambit Private Limited Axis Capital Limited
Registrar	Link Intime India Private Ltd	Link Intime India Private Ltd
Market Maker
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor	Anchor Investor	Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Akums Drugs and Pharmaceuticals IPO is up to ₹1,856.74 Cr whereas the issue size of the Interarch Building Products IPO is up to ₹600.29 Cr. The final issue price of Akums Drugs and Pharmaceuticals IPO is ₹679.00 per share and of Interarch Building Products IPO is ₹900.00 per share.

	Akums Drugs and Pharmaceuticals IPO	Interarch Building Products IPO
Face Value	₹2 per share	₹10 per share
Issue Price (Lower)	₹646.00 per share	₹850.00 per share
Issue Price (Upper)	₹679.00 per share	₹900.00 per share
Issue Price (Final)	₹679.00 per share	₹900.00 per share
Discount (Retail)
Discount (Employee)	₹64.00 per share	₹85.00 per share
Market Lot Size	22 shares	16 shares
Fresh Issue Size	1,00,14,727 shares	22,22,222 shares
Fresh Issue Size (Amount)	up to ₹680.00 Cr	up to ₹200.00 Cr
OFS Issue Size	1,73,30,435 shares	44,47,630 shares
OFS Issue Size (Amount)	up to ₹1,176.74 Cr	up to ₹400.29 Cr
Issue Size Total	2,73,45,162 shares	66,69,852 shares
Issue Size Total (Amount)	up to ₹1,856.74 Cr	up to ₹600.29 Cr

IPO Timetable

Akums Drugs and Pharmaceuticals IPO opens on Jul 30, 2024, while Interarch Building Products IPO opens on Aug 19, 2024. The closing date of Akums Drugs and Pharmaceuticals IPO and Interarch Building Products IPO is Aug 01, 2024, and Aug 21, 2024, respectively.

	Akums Drugs and Pharmaceuticals IPO	Interarch Building Products IPO
Anchor Bid Date	Jul 29, 2024	Aug 16, 2024
Issue Open	Jul 30, 2024	Aug 19, 2024
Issue Close	Aug 01, 2024	Aug 21, 2024
Basis Of Allotment (Tentative)	Aug 02, 2024	Aug 22, 2024
Initiation of Refunds (Tentative)	Aug 05, 2024	Aug 23, 2024
Credit of Share (Tentative)	Aug 05, 2024	Aug 23, 2024
Listing date (Tentative)	Aug 06, 2024	Aug 26, 2024
Anchor Lockin End date 1	Sep 01, 2024	Sep 20, 2024
Anchor Lockin End date 2	Oct 31, 2024	Nov 19, 2024

Financials

Akums Drugs and Pharmaceuticals IPO P/E ratio is , as compared to Interarch Building Products IPO P/E ratio of 15.04.

Akums Drugs and Pharmaceuticals IPO

Interarch Building Products IPO

Financial

Akums Drugs and Pharmaceuticals Limited Financial Information (Restated Consolidated)

Akums Drugs and Pharmaceuticals Limited's revenue increased by 13.81% and profit after tax (PAT) dropped by -99.19% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	3,516.37	3,266.53	3,069.05
Revenue	4,212.21	3,700.93	3,694.52
Profit After Tax	0.79	97.82	-250.87
Net Worth	709.50	717.19	621.98
Reserves and Surplus	861.01	868.70	787.79
Total Borrowing	491.56	536.97	357.95
Amount in ₹ Crore

Interarch Building Products Limited Financial Information (Restated)

Interarch Building Products Limited's revenue increased by 15% and profit after tax (PAT) rose by 6% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	755.01	675.03	543.75
Revenue	1,306.32	1,136.39	840.86
Profit After Tax	86.26	81.46	17.13
Net Worth	262.65	343.8	262.65
Total Borrowing	3.36	11.38	3.36
Amount in ₹ Crore

Promoter Shareholding (Pre-Issue)

84.94%

87.53%

Promoter Shareholding (Post-Issue)

59.9%

P/E Ratio

15.04

Market Cap

₹1497.43 Cr.

ROE

0.11%%

19.40%%

ROCE

3.37%%

25.79%%

Debt/Equity

0.69

-0.11

EPS

₹59.84

RoNW

-0.57%

22.26%%

Shares Offered

In the Akums Drugs and Pharmaceuticals IPO retail investors (RII) are offered 27,12,424 shares while in Interarch Building Products IPO retail investors are offered 27,12,424 shares. Qualified institutional buyers (QIB) are offered 81,37,276 shares in Akums Drugs and Pharmaceuticals IPO and 13,29,526 shares in Interarch Building Products IPO.

	Akums Drugs and Pharmaceuticals IPO	Interarch Building Products IPO
Anchor Investor Reserveration	1,22,05,912 shares	19,94,288 shares
Market Maker Reserveration
QIB	81,37,276 shares	13,29,526 shares
NII	40,68,637 shares	9,97,145 shares
RII	27,12,424 shares	23,26,671 shares
Employee	2,43,902 shares	24,539 shares
Others
Total	1,51,62,239 shares	46,77,881 shares

Bids Received (Subscription)

Akums Drugs and Pharmaceuticals IPO subscribed 63.44x in total, whereas Interarch Building Products IPO subscribed 93.79x.

	Akums Drugs and Pharmaceuticals IPO	Interarch Building Products IPO
QIB (times)	90.09x	197.29x
NII (times)	42.10x	130.91x
Big NII (times)	47.43x	148.31x
Small NII (times)	31.45x	96.11x
RII (times)	20.80x	19.46x
Employee (times)	4.14x	25.75x
Other (times)
Total (times)	63.44x	93.79x

Compare with others

Akums Drugs and Pharmaceuticals IPO	Interarch Building Products IPO
Interarch Building Products IPO	Gala Precision Engineering IPO
Orient Technologies IPO	Baazar Style Retail IPO
Unicommerce eSolutions IPO	Bajaj Housing Finance IPO
Brainbees Solutions (Firstcry) IPO	ECO Mobility IPO
Ceigall India IPO	Premier Energies IPO
Sanstar IPO	Orient Technologies IPO
Bansal Wire IPO	Unicommerce eSolutions IPO
Emcure Pharma IPO	Brainbees Solutions (Firstcry) IPO
OLA Electric IPO	Ceigall India IPO
Vraj Iron and Steel IPO	Akums Drugs and Pharmaceuticals IPO

Comments

Add a public comment...